Cerebral venous and sinus thrombosis associated with subcutaneous immunoglobulin injection and oral contraceptive use

Neurological Sciences

Volumn 33, Issue 3, 2012, Pages 627-629

  Min, Jiangyong ^a   Bhatt, Archit ^a   Aburashed, Rany ^a   Burton, Stephen ^a  

^a Michigan State University   (United States)

Author keywords

Cerebral sinus thrombosis; Oral contraceptives; Subcutaneous injection of immunoglobulin (SIG)

Indexed keywords

DROSPIRENONE; ETHINYLESTRADIOL; IMMUNOGLOBULIN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CEREBRAL SINUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FACE DISORDER; FEMALE; FRONTAL LOBE; HEADACHE; HEMIPARESIS; HUMAN; IMMUNE DEFICIENCY; MAGNETIC RESONANCE ANGIOGRAPHY; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY POLYCYSTIC DISEASE; PARESTHESIA; PARIETAL LOBE; VEIN ANASTOMOSIS;

CONTRACEPTIVES, ORAL; FEMALE; HUMANS; IMMUNOGLOBULINS; INJECTIONS, SUBCUTANEOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; SINUS THROMBOSIS, INTRACRANIAL; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84863986602     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0778-y     Document Type: Article

References (10)

1. Marie I, Maurey G, Herve F, Hellot MF, Levesque H (2006) Intravenous immunoglobulin-associated arterial and venous thrombosis: report of a series and review of the literature. Br J Dermatol 155: 714-721 (Pubitemid 44352551)
2. Evangelou N, Littlewood T, Anslow P, Chapel H (2003) Transverse sinus thrombosis and IVIG treatment: a case report discussion of risk-benefit assessment for immunoglobulin treatment. J Clin Pathol 56: 308-309 (Pubitemid 36459804)
3. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombib-gene mutation and in users of oral contraceptives. N Engl J Med 338: 1793-1799
4. de Bruijn SF, Stam J, Vandenbroucke JP (1998) Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Lancet 351: 1404 (Pubitemid 28210002)
5. Bousser MG, Chiras J, Bories J, Castaigne P (1985) Cerebral venous thrombosis: a review of 38 cases. Stroke 16: 199-213 (Pubitemid 15144722)
6. Wolberg AS, Kon RH, Monroe DM, Hoffman M (2000) Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. Am J Hematol 65: 30-34
7. Crouch ED, Watson LE (2002) Intravenous immunoglobulinrelated acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura: a case report and literature review. Angiology 53: 113-117 (Pubitemid 34141900)
8. Grillo JA, Gorson KC, Ropper AH, Lewis J, Weinstein R (2001) Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Neurology 57: 1699-1701 (Pubitemid 33055492)
9. Sherer Y, Levy Y, Langevitz P, Rauova L, Fabrizzi F, Shoenfeld Y (2001) Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology 62: 133-137 (Pubitemid 32260852)
10. Vandenbroucke JP, Rosing J, Bloemenkamp KWM, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendaal FR (2001) Oral contraceptives and the risk of venous thrombosis. New Eng J Med 344: 1527-1535 (Pubitemid 32429213)